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Abstract
Ozone and lipopolysaccharide (LPS) are environmental pollutants with adverse health effects
noted in both healthy and asthmatic individuals. The authors and others have shown that inhalation
of ozone and LPS both induce airway neutrophilia. Based on these similarities, the authors tested
the hypothesis that common biological factors determine response to these two different agents.
Fifteen healthy, nonasthmatic volunteers underwent a 0.4 part per million ozone exposure for 2 h
while performing intermittent moderate exercise. These same subjects underwent an inhaled LPS
challenge with 20,000 LPS units of Clinical Center Reference LPS, with a minimum of 1 month
separating these two challenge sessions. Induced sputum was obtained 24 h before and 4–6 h after
each exposure session. Sputum was assessed for total and differential cell counts and expression of
cell surface proteins as measured by flow cytometry. Sputum supernatants were assayed for
cytokine concentration. Both ozone and LPS challenge augmented sputum neutrophils and
subjects’ responses were significantly correlated (R = .73) with each other. Ozone had greater
overall influence on cell surface proteins by modifying both monocytes (CD14, human leukocyte
antigen [HLA]-DR, CD11b) and macrophages (CD11b, HLA-DR) versus LPS where CD14 and
HLA-DR were modified only on monocytes. However, LPS significantly increased interleukin
(IL)-1β, IL-6, and tumor necrosis factor (TNF)-α, with no significant increases seen after ozone
challenge. Ozone and LPS exposure in healthy volunteers induce similar neutrophil responses in
the airways; however, downstream activation of innate immune responses differ, suggesting that
oxidant versus bacterial air pollutants may be mediated by different mechanisms.
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A wide variety of pollutants have been associated with adverse health effects in healthy
populations and those with chronic diseases, such as asthma. Among the most commonly
encountered pollutants are ozone (O3) and particulate matter. There are a number of
mechanisms by which O3 may impact health outcomes. Experimental O3 challenge studies
of normal volunteers reveal three effects of ozone: a relatively immediate and temporary
restrictive lung function defect, increased airway inflammation, and increased non-specific
airway reactivity. The immediate effect of O3 on lung function tends to be of short duration,
whereas inflammatory responses can persist at least 24 h, particularly in GSTM1-null
individuals (Bernstein et al., 2004; Peden, 2005, 2008).
A significant constituent of particulate matter (PM) is lipopolysaccharide (LPS), which is
important in both outdoor and indoor environments. LPS is a prototypic pathogen-associated
molecular pattern (PAMP) moiety that activates airway monocytes and macrophages
through interaction with CD14 and the Toll-like receptor 4 (TLR4). Inhalation of LPS
activates macrophages, which induce neutrophilic inflammation of the airways. We have
previously reported that 20,000 EU doses of Clinical Center Reference LPS (CCRE), a level
equivalent to that found at many work-places, cause an influx of neutrophils in the airways
of both allergic asthmatic and normal volunteers and that there is a strong correlation
between the sputum macrophage CD14 expression and LPS-induced polymorphonuclear
neurophil (PMN) influx (Alexis et al., 2001).
We have found that inhalation of O3 causes a similar type of airway inflammatory response
to that seen with inhaled LPS challenge. Like LPS challenge, O3 inhalation induces airway
neutrophilia and increases levels of cytokines (Peden, 2008). In addition, we have reported
that following challenge with either O3 or LPS, sputum monocytes and macrophages have
increased expression of a number of important cell surface proteins that mediate innate and
acquired immune responses, including CD11b, CD14, CD86, and human leukocyte antigen
[HLA]-DR (Alexis et al., 2004, 2005, 2008; Lay et al., 2007). O3 and LPS also enhance
response to inhaled allergen in allergic subjects (Molfino et al., 1991; Ball, Folinsbee et al.,
1996; Jorres et al., 1996; Eldridge and Peden, 2000; Boehlecke et al., 2003; Chen et al.,
2004; Schaumann et al., 2008). We hypothesize that increased response to allergen is due, at
least in part, to changes in immune regulatory proteins on the surface of airway monocytes
and macrophages. We have also reported that pretreatment with inhaled corticosteroids
inhibit both O3 and LPS-induced airway inflammation in humans in vivo (Alexis and Peden,
2001; Alexis et al., 2008). Taken together, these observations suggest that O3 and LPS exert
similar proinflammatory effects in the airway.
The pathways mediating LPS- and O3-induced airway inflammation share some common
features. Response to LPS is mediated to a great extent by interactions between LPS-binding
protein, mCD14, sCD14, and TLR4. LPS-binding protein and CD14 bind LPS and facilitate
its ligation to TLR4, which initiates MyD88-mediated signaling, ultimately causing nuclear
factor (NF)-κB activation and production of a variety of proinflammatory cytokines,
including interleukin (IL)-1β and tumor necrosis factor (TNF)-α (Means et al., 2000;
Beutler, 2002; Leung et al., 2005). Although the signaling pathways for O3 are much less
well understood, it is known that O3 challenge of epithelial cells results in NF-κB activation
and production of a variety of mediators such as IL-6, IL-8, prostaglandin E2 (PGE2),
leukotriene B4 (LTB4), thromboxane B2 (TXB2), fibronectin, plasminogen activator, and
elastase (McKinnon et al., 1993; Devlin et al., 1994; Jaspers et al., 1997, 1998; Nichols et
al., 2001) Thus, both O3 and LPS likely activate similar pathways to regulate airway
inflammation.
Hernandez et al. Page 2













To test the hypothesis that O3 and LPS share similar immunoinflammatory response
patterns, we recruited volunteers who completed an O3 study (0.4 ppm, 2 h) to undertake an
inhalation challenge study to 20,000 EU of LPS. We hypothesized that airway neutrophil
responses to O3 would correlate with those to inhaled LPS. As secondary measures, we also
examined the comparative effect of O3 and LPS on inflammatory cytokine levels (IL-1β,
IL-6, IL-8, and TNF-α) and expression of cell surface proteins CD11b, CD14, CD86, and
HLA-DR on airway monocytes and macrophages.
Methods
Volunteer recruitment and inclusion criteria
These protocols were reviewed and approved by the University of North Carolina
Committee on the Rights of Human Subjects (Institutional Review Board). All subjects
underwent a physical examination, a routine blood panel with complete blood count (CBC)
and differential and allergy skin testing. Subjects were required to have a negative
methacholine challenge. Female subjects had to have a negative urine pregnancy test prior to
challenge and all volunteers were required to be free of chronic cardiovascular or respiratory
illness, and be free of acute respiratory illness within 4 weeks of O3 challenge. All subjects
had forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) ≥ 80%
predicted and FEV1/FVC ≥ 75% predicted normal for height and age, and were nonsmokers
with no smoking history. All subjects were screened for their ability to provide an adequate
induced-sputum sample during their training session. There was a minimum of 1-month time
separating O3 and LPS challenges, with an average of 6 months separating challenge
sessions for this cohort of subjects.
Lung function testing
Spirometry testing was preformed according to American Thoracic Society/European
Respiratory Society (ATS/ERS) recommendations using the Viasys VMax 229 series
spirometers. All subjects were seated, and at least three maneuvers were obtained, with the
best of the three reported.
Ozone exposure and LPS challenge protocols
Ozone inhalation challenge—The O3 exposures were conducted in an O3 exposure
chamber at the US Environmental Protection Agency (EPA) Human Studies Facility on the
campus of the University of North Carolina, Chapel Hill, NC. Each subject was exposed to
O3 (0.4 ppm) for 2 h while performing four 15-min sessions of intermittent moderate
exercise (minute ventilation or VEmin = 30 – 40 L/min) on a treadmill, separated by 15 min
of seated rest. Spirometry, breath sounds, and vital signs were assessed before and
immediately after exposure. Sputum was obtained 4–6 h postexposure and processed as
previously described (Alexis et al., 2003, 2006). Sputum was assessed for total and
differential cell counts, flow-cytometric assessmemt of CD11b, CD14, CD86, and HLA-DR
on macrophages and monocytes (Lay et al., 2007, 2009). Sputum supernatants were also
assessed for cytokine concentration.
LPS (Clinical Center Reference Endotoxin [CCRE]) inhalation challenge—The
study protocol consisted of 3 consecutive days and is similar to protocols previously
employed by our group (Alexis et al., 2005, 2009) The first day of each study period was for
baseline measurements of spirometry, venipuncture for complete blood count (CBC)
analysis, vital signs, symptom score, and induced sputum endpoints. On the second day,
baseline spirometry, vital signs, and symptom scores were recorded immediately before
inhalation challenge. CCRE (20,000 EU) was provided by the National Institutes of Health
Clinical Center and is referred to as Clinical Center Reference Endotoxin (CCRE).
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Spirometry was measured once each hour for 6 h after the inhalation challenge. Induced
sputum was performed 6 h after the inhalation challenges. After the completion of the
induced sputum procedure, vital signs and symptom scores were recorded, and the subjects
were observed for 1 h prior to discharge from the laboratory. Follow-up measurements of
spirometry, vital signs, and symptom scores were recorded on the following morning (third
day).
Sputum induction and processing
Subjects provided an induced sputum sample during the screening visit and at 4–6 h after the
O3 exposure, and 6 h after the inhaled CCRE challenge. Sputum induction and processing
methods have been previously described in detail and are referenced in the print article. In
brief, three 7-min inhalation periods of nebulized hypertonic saline (3%, 4%, 5%)
(DeVilbiss UltraNeb 99 ultrasonic nebulizer) were followed by expectoration of sputum into
a sterile specimen cup. A cell-enriched “select” sample was obtained by plucking visible
clumps of cells and cell-rich mucus “plugs” from the raw sample to separate them from
noncellular portions of the sample. This was then treated with a dilute (0.1%) solution of
dithiothrietol (DTT; Sputolysin; Calbiochem, San Diego, CA) in Dulbecco’s phosphate
buffered saline (DPBS) to digest mucus. Following centrifugation (500 × g, for 10 min),
aliquots of sputum supernatant were immediately frozen and stored at −80°C and the cell
pellet was suspended in a small volume of Hanks balanced salt solution (HBSS). Cell
viability (trypan blue exclusion) and total cell counts were assessed in a Neubauer
hemacytometer and differential cell counts were performed on cytocentrifuged cells stained
with a modified Wright’s stain, (Hema-Stain-3; Fisher Scientific). A portion of the cells
were immediately used for flow-cytometric assays.
Flow cytometry
Cell surface markers—Expression of selected cell surface molecules on sputum
leukocytes was quantified via multicolor flow cytometry (FCM) using a BD LSR-II flow
cytometer (BD Immunocytometry Systems; San Jose, CA). These included molecules
associated with antigen presentation and specific immunity (CD86/B7.2, HLA-DR/MHC-
II,), as well as innate immune function (CD11b/CR3, CD14/LPS receptor). First, sputum
leukocytes were differentiated from cellular debris, bacteria, yeast, and squamous and
bronchial epithelial cells by gating on CD45 (pan-leukocyte marker)–positive cells.
Leukocyte populations were further differentiated by various specific gating strategies based
on a combination of light scatter properties (forward scatter [FSC] reflects cell size; side
scatter [SSC] reflects cell granularity/density), differential expression of CD45 (pan-
leukocyte marker), and select surface lineage markers. For example, PMNs were defined as
CD16high/CD64dim/CD14dim/HLA-DRdimcells, whereas monocytes were defined as
CD14high/CD64high/HLA-DRhigh cells and further differentiated from macrophages by
CD45 expression and robust differential SSC expression. Up- or down-regulation of specific
surface molecules was quantified as a change in the mean fluorescent intensity (MFI) of the
gated population. Fluorochrome-labeled antibodies were obtained from BD Biosciences
(CD11b-PE-CY5, CD45-APC-Cy7, HLADR- PerCP) and Beckman-Coulter (CD14-APC,
CD86-PE). Appropriate, nonspecific, labeled isotypic control antibodies were also obtained
from these sources. Monocyte cell counts were determined using percentages within the
monocyte gate as determined by fluorescence-activated cell sorting (FACS) analysis,
together with the total cell count as determined from hemacytometry. Unlike macrophages,
monocyte quantification was not based on microscopically read cytospin slides.
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Cytokines from sputum supernatants were measured using multiplex technology (Meso
ScaleDiscovery/MSD, Gaitherburg, MD). Each sample was analyzed with the HumanMIP-1
alpha Ultra Sensitive Kit (lot no. K0031370) and the Human TH1/TH2 10-Plex Ultra
Sensitive Kit (lot no. K0031431). All supernatant samples were diluted 1:4 and had a final
dithiothreitol (DTT) concentration of <1 mM where no deleterious effects have been
observed using the MSD platform.
Statistical analysis
Change in cell counts/mg, differential percentage (sputum), mean fluorescence intensity
measures (flow cytometry), and cytokine values pre- and post-O3 and LPS exposures was
analyzed using the nonparametric paired Wilcoxon signed rank test. Correlations between
O3 and LPS (CCRE) responses for each outcome measure (responses defined as fold change
from baseline values) were assessed using the Spearman correlation technique (R).
Significance was set at p = .05 for all tests.
Results
Subject characteristics
Demographic data for 15 healthy volunteers who completed a challenge study to 0.4 ppm O3
and were then recruited for challenge with 20,000 EU of CCRE are presented in Table 1.
Four subjects were atopic as defined by positive skin prick testing to a panel of
environmental allergens, though none were symptomatic at the time of either O3 or CCRE
challenge.
General response to O3 and CCRE
Challenge to both O3 and CCRE were well tolerated, with no adverse events being observed
in any of these volunteers. Immediately following exposure to O3 the FVC was 88.2% ±
1.5% of baseline and the FEV1 was 84.15% ± 1.8% of baseline, with full recovery occurring
by 24 h. This is an expected response to O3. There was no significant effect of inhaled
CCRE on lung function.
Effect of O3 and CCRE on airway neutrophilia
As shown in Figure 1A, we found that both O3 and CCRE resulted in a significant increase
over baseline of % PMNs (O3: 42.1% ± 5.0% versus 63.9% ± 3.9%, p = .0002; CCRE:
33.02% ± 6% versus 49.20% ± 4%, p = .02). The absolute number of neutrophils (PMNs/
mg) were significantly increased above baseline following O3 challenge (766.1 ± 278.0
versus 1237 ± 329.6, p = .003) and elevated following CCRE but not significantly above
baseline (633.8 ± 293.7 versus 810.6 ± 396.6), as denoted in Figure 1B. The total cell counts
and absolute numbers of leukocyte subsets as well as percentages are shown in Table 2.
Cytokine responses to O3 and CCRE
Of the sputum samples recovered from volunteers, we generally had adequate sample to
assess sputum cytokines from a majority of the 15 volunteers who underwent O3 and CCRE
challenge. Specifically, we examined the effect of these agents on sputum IL-1β (n = 14 for
O3, n = 12 for CCRE), IL-6 (n = 12 for both O3 and CCRE), IL-8 (n = 13 for O3 and n = 11
for CCRE), and TNF-α (n = 14 for O3 and n = 12 for CCRE). No significant increases in any
of these cytokines were observed after O3 challenge. CCRE challenge resulted in significant
increases in IL-1β, IL-6, and TNF-α. These results are shown in Figure 2.
Hernandez et al. Page 5













Changes in monocyte and macrophage cell surface proteins following challenge with O3
and CCRE
Of the sputum samples recovered from volunteers, we generally had adequate sample to
assess changes in selected cell surface proteins on sputum monocytes and macrophages from
a majority of the 15 volunteers who underwent O3 and CCRE challenge. Specifically, we
assessed the effect of O3 and CCRE on expression of monocyte and macrophage CD11b,
CD14, CD86, and HLA-DR. The effect of O3 and CCRE on surface protein expression on
monocytes and macrophages are depicted in Figures 3 and 4, respectively. In general,
monocytes exhibited greater changes in surface protein to either stimulus than macrophages.
CD11b was significantly increased only after O3 challenge in both monocytes and
macrophages.
Correlation of the neutrophil response following O3and CCRE challenge
We examined the correlation of the neutrophil response following O3 and CCRE challenge
in 13 subject pairs. The neutrophil response was measured as the fold change from baseline
in 13 subject pairs for % PMNs and PMNs/mg sputum. Linear regression analysis was
performed and a best-fit line was generated for the data. There was a significant correlation
in % PMNs in induced sputum. The strength of the correlation was affected by inclusion of
an outlier, whose % PMNs at baseline for the CCRE challenge session (46.8%) was elevated
compared to her baseline value for ozone challenge (16%). We speculate that she may have
had a subclinical viral infection. With inclusion of this outlier, the r value was .59, with a p
value of .03. Figure 5 shows a regression line generated without the outlier (r = .73, p = .
007). The outlier is denoted by an open circle. This correlation did not hold for PMNs/mg (r
= .14, p = .65). Correlation analyses applied to other differential cells (macrophages) and
cell surface proteins such as monocyte CD14 (r = −.2, p = .6, N = 11 pairs) and HLA-DR (r
= .42, p = .23, N = 11 pairs) revealed no significant associations between O3 and CCRE.
Discussion
Ozone and LPS are both known to induce airway inflammation following inhalation
challenge. As noted in the Introduction, there are a number of similarities between the
airway responses of these two agents in humans, including airway neutrophilia, changes in
surface marker expression on airway monocytes and macrophages, and production of
proinflammatory cytokines. Mechanistic studies in animals suggest that at least some
responses to O3 are mediated through TLR4, the primary LPS receptor. Kleeberger and
colleagues used LPS responsive CH3/HeOuJ mice and LPS-resistant HeJ mice that differ
only at a polymorphism in the coding region of TLR4 to determine the effect of TLR4 on
response to O3 (Kleeberger et al., 2000; Cho and Kleeberger, 2007). They found that one
response phenotype, airway hyperpermeability, was increased in the CH3/HeOuJ mice,
suggesting that TLR4 modulates this response to O3. Hollingsworth et al. used mice in
which TLR4 had been deleted and compared response to LPS and O3 (Hollingsworth et al.,
2004). They found that acute neutrophilia following LPS, but not O3, was ablated in the
TLR4-deficient mice, but that airway reactivity following subacute O3 exposure was
decreased in TLR4-deficient mice compared to wild-type mice. Taken together, these
observations suggest that TLR4 may modulate at least some O3-induced responses.
In this study, we examined the airway inflammatory response of 15 human volunteers to 0.4
ppm O3 and 20,000 EU CCRE (LPS) in order to directly compare an individual’s response
to these two agents, and to determine if there was a correlation between these responses.
Such a correlation would be consistent with the hypothesis that common biological factors
determine response to these two different agents. We chose these levels of O3 and LPS
because we have previously found that they induce similar levels of sputum neutrophilia, a
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robust marker of airways inflammation, while avoiding undesirable systemic side effects to
our study population. We also chose a 4–6-h time point after both exposure sessions in order
to be able to make direct comparisons between exposures. Schelegle et al. showed that the
percent of neutrophils in proximal airway samples with BAL was maximal 6 h after a 0.3
ppm O3 exposure, compared to 1 and 24 h after O3 exposure (Schelegle et al., 1991). Our
group has previously shown maximal percent neutrophils as well as neutrophils/mg of
sputum after a 0.4 ppm O3 exposure in induced sputum at 6 h compared to 24 h (Lay et al.,
2007) without segregating for GSTM1 genotype, as was the case for the current study.
Studies examining the time course after LPS challenge are more limited; a 60-μg inhaled
LPS challenge induced maximal induced sputum neutrophilia (PMNs/ml) in normal
volunteers at 24 h after LPS challenge compared to baseline or 6-h values, with no
difference in % neutrophils compared to baseline at the 6- and 24-h time points (Nightingale
et al., 1998). Because of the substantial difference in a 60-μg dose of LPS compared to our
equivalent of a 5-μg dose, it is difficult to speculate if comparison of sputum neutrophilia or
other markers at a 24-h time point would have significantly changed our findings.
In this study, we found that both agents increased percent neutrophils in sputum compared to
baseline values. The fold change in % neutrophils between O3 and LPS was the only
variable that was significantly correlated among individuals. Cell surface protein responses
such as CD14 and HLA-DR were not correlated even though both were significantly
increased following O3 and LPS challenge. One possible explanation may be that the range
of surface marker response following LPS challenge was more limited compared to O3.
Indeed we found that fold change from baseline of CD14 and HLA-DR was greater with O3
exposure than with LPS challenge. Correlations would be more difficult to determine under
these circumstances and would have required a larger sample size than that used here. The
4–6-h time point used in our study also presents another significant limitation in determining
these correlations, as these cell surface markers could potentially have been further modified
with time.
In general, the dose of O3 used in this study generated a more vigorous cellular response
than LPS in terms of neutrophil recruitment to the airways and cell surface marker
expression on both monocytes and macrophages. This observation may be accounted for by
the dose of LPS used in our human challenge exposure protocols. Michel and colleagues
have shown that much higher doses of inhaled LPS (50 μg LPS, approximately 10 times the
dose used in our study) elicited robust neutrophil responses in induced sputum (Michel et
al., 1997) equivalent to those with 0.4 ppm O3 used in this study. However, this higher dose
of LPS has been shown to produce systemic side effects such as elevations in temperature
and subjective symptoms, thereby limiting its use in human subjects. It can be argued that
the differences in response to these agents may also be due to differences in inflammatory
signaling by stimuli that directly activate macrophages as opposed to exposures that can
cause sterile tissue injury. Devlin et al. showed that healthy volunteers who underwent a 2-h
0.4 ppm O3 exposure had evidence of tissue injury, such as elevated lactate dehydrogenase
(LDH) and protein, in their bronchoalveolar lavage fluid at 1 and 18 h after the exposure
(Devlin et al., 1996). The increased PMN response to O3 relative to LPS noted in our study
may be due to a broader range of inflammatory signaling induced by injury to the airway
epithelium and its extracellular matrix, such as via the release of hyaluronic acid
(Manzanares et al., 2007), which interacts with TLR4 (Taylor et al., 2007; Garantziotis et
al., 2009), and through the release of potent neutrophil chemoattractants such as IL-8 and
LTB4 (McKinnon et al., 1993; Devlin et al., 1994). Although LPS exposure will activate
airway macrophages through its interaction with TLR4, we have not shown that challenge
with 20,000 EU CCRE augments levels of IL-8 in induced sputum (Alexis et al., 2005).
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Interestingly LPS caused a greater effect on cytokine levels than O3. There are two potential
explanations for this difference in response. The first may be temporally related to our
sampling time. Devlin et al. showed that IL-6 and PGE2 levels were higher 1 h after
exposure than 18 h after a 2-h 0.4 ppm O3 exposure (Devlin et al., 1996). We sampled
induced sputum 4–6 h after the end of the 2-h O3 exposure session, potentially impairing our
ability to sample IL-6 or other relevant cytokines at their peak levels. We have shown that
particulate matter containing LPS appears to initiate proinflammatory cytokine production at
a slower rate, where macrophage mRNA TNF-α, but not protein, was detected 2 h after the
end of the exposure (Alexis et al., 2006). We routinely sample induced sputum supernatants
for protein 6 h after a CCRE challenge because of this time lag in cytokine production with
LPS.
Another possibility to explain the differences in cytokine profiles following these challenges
is likely due to signal transduction cascades responding to O3 versus LPS challenge. The
increased IL-1β, IL-6, and TNF-α levels following LPS (versus O3) challenge may occur
because these cytokines are more strongly associated with macrophage response than with
epithelial cell responses. Both % macrophages and the absolute number of macrophages
were greater following LPS than O3 challenge (Table 2); LPS activation of a greater number
of airway macrophages could account in large part for this enhanced cytokine response
because the number of macrophages significantly exceeded the number of monocytes
following LPS challenge (data not shown). Collectively, our data suggest that injury to
airway tissues by O3 likely results in the production of a cascade of mediators, which results
in more robust airway neutrophilia, whereas the effects of LPS inhalation may be more
limited to macrophage activation in the airway. It will be informative in the future to
compare these mediator levels at later time points, as the late-phase cytokine milieu may
provide further clues as to potentially shared and/or distinct airway inflammatory responses
to these two pollutants.
Both agents resulted in recovery of monocytes from sputum with increased expression of
CD14 and HLA-DR, and a trend for increased CD86 expression. Whereas CD11b and HLA-
DR were increased in both monocytes and macrophages after O3 challenge, CD14 and
CD86 were relatively unaffected. This suggests that macrophages, as compared to newly
recruited monocytes, are less likely to undergo phenotype modification from O3 and LPS.
This may be a function of their already mature state in the airways and hence committed
phenotype, whereas monocytes have a less committed phenotype and are vulnerable to
modifying agents. The increased expression of cell surface proteins that mediate antigen
presentation (HLA-DR, CD86) following both O3 and LPS are indeed consistent with our
own observations that show that O3 and inhaled LPS enhance response to inhaled allergen
(Boehlecke et al., 2003; Peden, 2008). Furthermore, we have shown that the number of
monocytes with modified surface phenotypes are elevated following O3 exposure, resulting
in an overall increased antigen-presenting capability in the airways (Lay et al., 2007).
Although we only saw direct correlations between neutrophil responses to O3 and LPS,
common risk factors may still modulate response and adverse health effects associated with
exposure to both O3 and LPS. A number of candidate genetic factors have been identified
which may modulate response to a variety of pollutants and irritants (London, 2007). The O3
protocol from which volunteers were recruited for this study was focused on the
examination of the role of the GSTM1-null genotype in modulating response to ozone. We
found that GSTM1-null volunteers had increased airway inflammation 24 h after completion
of the challenge than did those who were sufficient in GSTM1 (Alexis, Zhou et al., 2009). In
addition to modulating the response to O3, GSTM1-null individuals have been reported to
have increased susceptibility to diesel exhaust (Gilliland et al., 2004) and tobacco smoke
(Gilliland et al., 2002, 2006).
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Although LPS is not an oxidant per se, cells activated by LPS do generate oxidants, and
overall responses to LPS likely involve oxidant-dependent mechanisms. The GSTM1 gene
is among a large number of antioxidant and cell defense genes regulated by the transcription
factor nuclear erythroid 2 p45-related factor 2 (NRF2) (Kensler et al., 2007). We could not
identify reports examining GSTM1 as a modulator of response to LPS. However, there are
reports demonstrating that cellular responses to LPS are modified by NRF2 (Thimmulappa
et al., 2006), and NRF2-deficient mice are much more sensitive to the effect of experimental
sepsis induced by LPS than are wild-type mice (Thimmulappa et al., 2006). Thus, GSTM1
or other NRF2-regulated genes may be candidate genes that modulate response to LPS as
well as O3. Our study included 15 individuals, 8 of whom were GSTM1+ and 7 of whom
were GSTM1−. Although this sample size is too limited to make meaningful conclusions
about the effect of GSTM1 status on LPS responses, it will be important to examine this
genotype in a larger study population to define the effect of antioxidant defense genes on
LPS-induced airway inflammation.
To our knowledge, this is the first study in which healthy volunteers underwent challenge
with O3 and LPS to compare the inflammatory responses to these two agents within the
same individuals. Our results indicate that an individual’s ability to generate a neutrophil
response in the airways following O3 exposure is significantly associated with their ability to
do the same following inhaled LPS challenge. Moreover, both pollutants up-regulate
mCD14 and HLA-DR on sputum monocytes. However, the cytokine milieu is not shared by
these two pollutants. In summary, we report that O3 and LPS induce neutrophilic
inflammation and modify markers of innate immunity. These observations, coupled with
these pollutants’ ability to augment response to inhaled allergen in allergic volunteers,
suggest that other common mechanisms need to be explored to fully understand the risk
factors associated with these two agents.
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Neutrophil responses comparing O3 and CCRE challenge. Baseline values are labeled as
pre-O3 and pre-LPS. O3 and CCRE exposure both increased % neutrophils in induced
sputum (A), whereas only ozone significantly increased neutrophils per milligram of sputum
(B). (See colour version of this figure online at www.informahealthcare.com/ipi)
Hernandez et al. Page 12














Cytokines from sputum supernatants comparing O3 and CCRE challenge. Baseline values
are labeled as pre- O3 and pre-LPS. Only CCRE challenge significantly increased the
concentration of IL-1β (A), IL-6 (B), and TNF-α (D). Neither O3 nor CCRE challenge
changed levels of IL-8 (C). (See colour version of this figure online at
www.informahealthcare.com/ipi)
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Cell surface markers of sputum monocytes comparing O3 and CCRE challenge. Baseline
values are labeled as pre-O3 and pre-LPS. CD11b (A) was up-regulated by O3 alone. CD14
(B) and HLA-DR (D) were up-regulated by O3 and CCRE. Neither challenge modality up-
regulated CD86 (C). CD11b n = 12 for O3 and n = 12 for CCRE; CD14 n = 14 for O3 and n
= 12 for CCRE; CD86 n = 13 for O3 and n = 11 for CCRE; and HLA-DR n = 13 for O3 and
n = 12 for CCRE. (See colour version of this figure online at
www.informahealthcare.com/ipi)
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Cell surface markers of sputum macrophages comparing O3 and CCRE challenge. Baseline
values are labeled as pre-O3 and pre-LPS. CD11b (A) and HLA-DR (D) were up-regulated
by O3 alone, whereas CD14 (B) and CD86 (C) were not affected by O3 or CCRE challenge.
CD11b n = 11 for O3 and n = 12 for CCRE; CD14 n = 12 for O3 and n = 12 for CCRE;
CD86 n = 11 for O3 and n = 11 for CCRE; and HLA-DR n = 12 for O3 and n = 12 for
CCRE.(See colour version of this figure online at www.informahealthcare.com/ipi)
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Correlation analysis comparing fold change from baseline % neutrophils in induced sputum.
x-axis denotes O3 challenge and y-axis denotes CCRE (LPS) challenge. N = 12 pairs to
generate the linear regression line. A positive correlation was noted between ozone- and
LPS-induced sputum neutrophilia (r = .73, p = .007). With inclusion of the outlier denoted
by the open circle, r = .59, p = .03.
Hernandez et al. Page 16
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